Minca Eugen C, Tubbs Raymond R, Portier Bryce P, Wang Zhen, Lanigan Christopher, Aronow Mary E, Triozzi Pierre L, Singh Arun, Cook James R, Saunthararajah Yogen, Plesec Thomas P, Schoenfield Lynn, Cawich Victoria, Sulpizio Scott, Schultz Roger A
Departments of Molecular and Anatomic Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
Cancer Genet. 2014 Jul-Aug;207(7-8):306-15. doi: 10.1016/j.cancergen.2014.08.005. Epub 2014 Aug 29.
Cytogenetic alterations are strong outcome prognosticators in uveal melanoma (UVM). Monosomy 3 (-3) and MYC amplification at 8q24 are commonly tested by fluorescence in situ hybridization (FISH). Alternatively, microarray analysis provides whole genome data, detecting partial chromosome loss, loss of heterozygosity (LOH), or abnormalities unrepresented by FISH probes. Nonfixed frozen tissue is conventionally used for microarray analysis but may not always be available. We assessed the feasibility of genomic microarray analysis for high resolution interrogation of UVM using formalin-fixed paraffin-embedded tissue (FFPET) as an alternative to frozen tissue (FZT). Enucleations from 44 patients (clinical trial NCT00952939) yielded sufficient DNA from FFPET (n = 34) and/or frozen tissue (n = 41) for comparative genomic hybridization and select single nucleotide polymorphism analysis (CGH/SNP) on Roche-NimbleGen OncoChip arrays. CEP3 FISH analysis was performed on matched cytology ThinPrep material. CGH/SNP analysis was successful in 30 of 34 FFPET and 41 of 41 FZT samples. Of 27 paired FFPET/FZT samples, 26 (96.3%) were concordant for at least four of six major recurrent abnormalities (-3, +8q, -1p, +6p, -6q, -8p), and 25 of 27 (92.6%) were concordant for -3. Results of CGH/SNP were concordant with the CEP3 FISH results in 27 of 30 (90%) FFPET and 38 of 41 (92.6%) FZT cases; partial -3q was detected in two CEP3 FISH-negative cases and whole chromosome 3, 4, and 6 SNP-LOH in one case. CGH detection of -3, +8q, -8p on FFPET and FZT showed significant correlation with the clinical outcome measures (metastasis development, time to progression, survival). Results of the UVM genotyping by CGH/SNP on FFPET are highly concordant with those of the FZT analysis and with those of the CEP3 FISH analysis, and therefore CGH/SNP is a practical method for UVM prognostication. Genome-wide coverage provides additional data with potential relevance to UVM biology, diagnosis, and prognosis.
细胞遗传学改变是葡萄膜黑色素瘤(UVM)强有力的预后指标。3号染色体单体(-3)和8q24处的MYC扩增通常通过荧光原位杂交(FISH)检测。另外,微阵列分析可提供全基因组数据,检测部分染色体缺失、杂合性缺失(LOH)或FISH探针未涵盖的异常情况。传统上非固定的冷冻组织用于微阵列分析,但并非总是可用。我们评估了使用福尔马林固定石蜡包埋组织(FFPET)替代冷冻组织(FZT)进行基因组微阵列分析以高分辨率检测UVM的可行性。44例患者(临床试验NCT00952939)的眼球摘除标本可从FFPET(n = 34)和/或冷冻组织(n = 41)中获得足够的DNA,用于在罗氏-尼姆根OncoChip阵列上进行比较基因组杂交和选择单核苷酸多态性分析(CGH/SNP)。对匹配的细胞病理学ThinPrep材料进行CEP3 FISH分析。CGH/SNP分析在34份FFPET样本中的30份以及41份FZT样本中的41份成功完成。在27对FFPET/FZT样本中,26对(96.3%)在六种主要复发性异常(-3、+8q、-1p、+6p、-6q、-8p)中的至少四种上结果一致,27对中的25对(92.6%)在-3上结果一致。CGH/SNP结果在30份FFPET样本中的27份(90%)以及41份FZT样本中的38份(92.6%)与CEP3 FISH结果一致;在两例CEP3 FISH阴性病例中检测到部分-3q,在一例中检测到3、4和6号全染色体SNP-LOH。在FFPET和FZT上通过CGH检测-3、+8q、-8p与临床结局指标(转移发生、进展时间、生存)显示出显著相关性。通过CGH/SNP对FFPET进行UVM基因分型的结果与FZT分析以及CEP3 FISH分析的结果高度一致,因此CGH/SNP是一种用于UVM预后评估的实用方法。全基因组覆盖提供了与UVM生物学、诊断和预后潜在相关的额外数据。